2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
Gastrointestinal Cancers BREAKWATER: Analysis of first-line encorafenib + cetuximab + chemotherapy in BRAF V600E-mutant metastatic colorectal cancer
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer